News

In PIONEER study, investigators outline successes.

John Pollack, MD, discusses gene therapy advancements in the first installment of his blog for Modern Retina.

American Society of Retina Specialists (ASRS) meeting offers scientific sessions, symposia, discussion groups, opportunities for attendees.

A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.

Investigators at Dartmouth College have found that eye contact during a conversation makes the discussion more appealing to its participants.

Dr. Breazzano discusses how clinicians can learn from the COVID-19 pandemic and prepare for future crises.

Investigators find that wearable aid offers improved mobility.

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.

A synopsis of the findings presented at EURETINA 2021 for ophthalmologists and retina specialists.

During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment.

In a presentation at the EURETINA 2021 Virtual Conference, Tunde Peto, MD, PhD, pointed out that while complications associated with diabetes develop over a long period, ophthalmologists today have an excellent understanding of diabetes-related eye changes.

During a presentation at the EURETINA 2021 Virtual Congress, Daniel Jones, PhD, discussed GA and emphasized the need for additional study to gain a better understanding of the burden experienced by patients.

In a presentation at the EURETINA 2021 Virtual Congress, Cristina Cristian, MD, noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

During a presentation at the EURETINA 2021 Virtual Congress, Anat Loewenstein, MD, MHA, discussed how artificial intelligence can optimize optical coherence tomography.

During a presentation at the EURETINA 2021 Virtual Congress, José-Alain Sahel, MD, explains that optogenetics involves the use of artificial photoreceptors from specific retinal cells to restore vision by transferring a gene that encodes for a light-sensitive protein that causes neuronal cells to respond to light stimulation.

This conference titled, “The Top Ten Things I Wish I Knew Sooner,” is the brainchild of Lisa M. Nijm, MD, JD, who has had the foresight to help young ophthalmologists negotiate the choppy waters of a new practice.

Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Chekitaan Singh, MD, discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.

Speaking during the EURETINA 2021 Virtual Congress, Marta Belmonte-Grau, MD, discussed the potential risk for posterior capsular rupture during cataract surgery.

Amid a surging COVID-19 pandemic, ophthalmologists in the path of Hurricane Ida are now dealing with the storm's impact.

Dr. Jorge Calzada's diabetic macular edema blog dives into his successful treatment of DME with MicroPulse.

Investigators find imaging method may be useful to monitor disease progression.

Organization looks to improve global eye care through ophthalmic education.

Mark Breazzano, MD, discusses his views on the future of telehealth for ophthalmologists and retina specialists.

Mark Breazzano, MD, discusses his research into the decrease in urgent and emergent procedures in ophthalmology, how he's handling it in his practice, and how to make patients more comfortable coming in to receive care.

Development of new animal model enhances study of genetic mutations.

Study examines immunomodulatory as a potential long-term treatment option.

Novel treatments may be on the horizon for the advanced form of age-related macular degeneration.